Clinical trial
Use of Rosiglitazone in the Treatment of Endometriosis
NCT00115661 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Terminated
Key facts
| NCT number | NCT00115661 |
|---|---|
| Title | Use of Rosiglitazone in the Treatment of Endometriosis |
| Official title | Treatment of Endometriosis Pain With Rosiglitazone: A Prospective Phase 2 Clinical Trial |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | Berlex Foundation |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 25 |
| Start date | Jul 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jun 24, 2005 |
| Last update posted | Oct 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: